(Q44306671)

English

Mucosal priming with PEI/DNA complex and systemic boosting with recombinant TianTan vaccinia stimulate vigorous mucosal and systemic immune responses

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Mucosal priming with PEI/DNA complex and systemic boosting with recombinant TianTan vaccinia stimulate vigorous mucosal and systemic immune responses (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

systemic immune response

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

author name string

Xianggang Huang

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Jianqing Xu

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Li Ren

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Lianxing Liu

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Yanmin Wan

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Ning Zhang

7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Hong Peng

8

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Yiming Shao

9

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

language of work or name

0 references

publication date

28 December 2006

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

2620-2629

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Systemic immunity and mucosal immunity are induced against human immunodeficiency virus Gag protein in mice by a new hyperattenuated strain of Listeria monocytogenes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Effect of CD8+ lymphocyte depletion on virus containment after simian immunodeficiency virus SIVmac251 challenge of live attenuated SIVmac239delta3-vaccinated rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Low levels of perforin expression in CD8+ T lymphocyte granules in lymphoid tissue during acute human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: evidence supporting a protective role for CTL in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Host determinants in HIV infection and disease. Part 1: cellular and humoral immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

AIDS pathogenesis: a finite immune response to blame?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Poly(ethylenimine) and its role in gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Aerosol delivery of robust polyethyleneimine-DNA complexes for gene therapy and genetic immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Enhanced gene expression in mouse lung after PEI-DNA aerosol delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

PEI - a potent, but not harmless, mucosal immuno-stimulator of mixed T-helper cell response and FasL-mediated cell death in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Intranasal immunization with inactivated influenza virus enhances immune responses to coadministered simian-human immunodeficiency virus-like particle antigens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Vaccination strategies for mucosal immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Transmission of HIV-1 during primary infection: relationship to sexual risk and sexually transmitted infections.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Ontogeny and specificities of mucosal and blood human immunodeficiency virus type 1-specific CD8(+) cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

New strategies for using mucosal vaccination to achieve more effective immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Identifying vaccine antigens and assessing delivery systems for the prevention of bacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Mucosal immunity: some historical perspective on host-pathogen interactions and implications for mucosal vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Suppression of the immune response by nasal immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Immunogenicity of an HIV-1 gag DNA vaccine carried by attenuated Shigella

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Nuclear targeting peptide scaffolds for lipofection of nondividing mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Intravascular and endobronchial DNA delivery to murine lung tissue using a novel, nonviral vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Intracellular route and transcriptional competence of polyethylenimine-DNA complexes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Nanoscopic structure of DNA condensed for gene delivery.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Gene delivery to the lung using protein/polyethylenimine/plasmid complexes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Prolonged organ retention and safety of plasmid DNA administered in polyethylenimine complexes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Prime-boost vaccination with HIV-1 Gag protein and cytosine phosphate guanosine oligodeoxynucleotide, followed by adenovirus, induces sustained and robust humoral and cellular immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.020

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2006.12.020

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44306671&oldid=2109323906"